object
investig
effect
integr
therapi
preval
length
hospit
manag
major
complic
parkinson
diseas
pd
south
korea
method
studi
retrospect
cohort
analysi
conduct
use
nation
health
insur
servicen
sampl
cohort
south
korea
patient
year
old
newli
diagnos
pd
identifi
integr
therapi
group
defin
patient
treat
korean
medicin
km
biomedicin
monotherapi
group
consist
patient
treat
biomedicin
alon
pd
diagnosi
preval
annual
length
hospit
pd
major
complic
dementia
depress
pneumoniasepsi
analyz
use
logist
regress
anova
ttest
propens
score
ps
match
ratio
result
ps
estim
match
cohort
use
analysi
includ
subject
integr
therapi
group
monotherapi
group
sex
age
index
year
comorbid
sever
disabl
neurolog
care
antiparkinson
medic
levodopa
ropinirol
pramipexol
selegilin
adjust
group
preval
hospit
due
pneumoniasepsi
time
ci
lower
integr
therapi
group
monotherapi
group
statist
signific
p
preval
annual
length
total
hospit
hospit
pd
dementia
depress
integr
therapi
group
show
posit
result
compar
monotherapi
group
differ
statist
signific
conclus
clearli
identifi
integr
therapi
km
biomedicin
pd
manag
better
treatment
patient
compar
biomedicin
monotherapi
howev
found
clue
better
result
integr
therapi
therefor
investig
increas
number
subject
need
confirm
find
present
herein
parkinson
diseas
second
frequent
neurodegen
diseas
alzheim
diseas
caus
imbal
inhibitori
action
dopamin
excitatori
action
acetylcholin
decreas
dopamin
rizek
et
al
delamarr
meissner
incid
preval
pd
increas
age
especi
one
reach
parkinson
diseas
patient
motor
symptom
includ
bradykinesia
rigid
rest
tremor
postur
instabl
howev
nonmotor
symptom
may
also
promin
includ
cognit
impair
depress
autonom
disturb
roger
et
al
gener
pd
caus
interact
genet
environment
factor
delamarr
meissner
pesticid
histori
melanoma
traumat
brain
injuri
also
report
increas
risk
factor
pd
promot
physic
activ
known
prevent
pd
ascherio
schwarzschild
levodopa
goldstandard
treatment
motor
symptom
pd
rizek
et
al
howev
pd
progress
worsen
time
current
cure
accordingli
necessari
treat
care
pdrelat
symptom
patient
elbaz
et
al
therefor
pd
patient
use
altern
therapi
includ
acupunctur
tai
chi
herbal
medicin
complement
standard
treatment
ghaffari
kluger
inde
previou
studi
shown
herbal
formula
acupunctur
tai
chi
might
safe
benefici
pd
patient
bega
zadikoff
cwiekalalewi
et
al
lee
lim
noh
et
al
et
al
addit
studi
find
benefit
use
biomedicin
km
concurr
pd
patient
leem
yang
et
al
jang
et
al
lee
et
al
present
studi
effect
integr
therapi
consist
biomedicin
km
manag
pd
patient
investig
citizen
south
korea
receiv
health
insur
medic
treatment
prescript
data
healthcar
institut
pharmaci
load
nation
databas
maintain
manag
nhi
nhi
built
nhisnsc
databas
consist
repres
anonym
data
extract
nation
health
insur
record
pertain
member
total
popul
follow
person
privaci
particip
protect
deidentif
data
nhisnsc
nd
version
nhisnsc
gener
data
mask
diagnos
includ
cancer
infect
diseas
therefor
nd
version
could
use
studi
retrospect
cohort
studi
elig
period
set
januari
start
date
nhisnsc
decemb
cohort
index
set
januari
decemb
followup
period
set
januari
decemb
end
nhisnsc
data
expir
date
patient
figur
cohort
patient
age
year
older
diagnos
pd
nhisnsc
establish
diagnosi
defin
code
base
korean
standard
classif
diseas
kcd
th
revis
intern
classif
diseas
patient
diagnos
pd
elig
period
exclud
therefor
newli
diagnos
pd
includ
figur
patient
divid
two
group
treatment
type
integr
therapi
group
receiv
biomedicin
km
monotherapi
group
treat
biomedicin
treatment
histori
pd
record
least
twice
form
patient
consid
receiv
treatment
howev
patient
receiv
treatment
exclud
figur
gener
outcom
pd
recoveri
manag
base
updr
scopa
peto
et
al
marinu
et
al
goetz
et
al
howev
nhisnsc
survey
examin
data
health
insur
claim
data
thu
studi
use
altern
outcom
demonstr
pd
complic
wellcontrol
altern
outcom
outcom
defin
preval
hospit
annual
length
hospit
pd
diagnosi
hospit
classifi
total
hospit
hospit
pd
hospit
due
major
complic
pd
studi
dementia
depress
pneumoniasepsi
consid
major
complic
kcd
dementia
depress
pneumoniasepsi
appli
confound
control
comparison
integr
therapi
group
monotherapi
group
studi
cci
calcul
use
kcd
code
nhisnsc
possibl
score
point
cci
give
weight
sever
comorbid
factor
affect
death
map
icd
code
clinic
review
quan
et
al
addit
sever
disabl
patient
includ
nhisnsc
consid
confound
adjust
biomedicin
treatment
treatment
group
treatment
period
neurolog
hospit
period
neurolog
antiparkinson
medic
levodopa
ropinirol
pramipexol
selegilin
also
consid
confound
zhuo
et
al
propens
score
ps
use
increas
level
causal
reveal
observ
studi
dagostino
specif
ps
use
match
subject
similar
characterist
two
group
sever
variabl
use
creat
ps
index
age
sex
index
year
cci
treatment
period
neurolog
hospit
period
neurolog
sever
disabl
antiparkinson
medic
comparison
ps
group
repeat
use
greedi
algorithm
match
continu
match
pair
parson
ps
fit
confirm
cstatist
hosmer
lemeshow
goodnessoffit
test
case
cstatist
valu
hosmer
lemeshow
goodnessoffit
test
consid
good
pvalu
higher
dagostino
maldonado
greenland
preval
annual
length
hospit
analyz
use
logist
regress
analysi
ttest
pvalu
consid
signific
addit
integr
therapi
group
divid
two
group
treatment
period
less
day
day
preval
annual
length
hospit
analyz
use
logist
regress
analysi
anova
anova
duncan
post
hoc
test
appli
pvalu
consid
signific
final
surviv
analysi
integr
therapi
group
monotherapi
group
perform
use
cox
proport
hazard
analysi
statist
analys
perform
use
sa
except
patient
diagnos
pd
prior
patient
treat
without
biomedicin
treatment
younger
year
total
patient
includ
cohort
treat
use
biomedicin
korean
medicin
receiv
biomedicin
alon
ps
estim
match
cohort
use
analysi
includ
subject
integr
therapi
group
monotherapi
group
figur
ps
match
consid
wellfit
base
cstatist
valu
pvalu
goodnessoffit
test
patient
characterist
base
confound
two
group
ps
match
compar
ps
match
characterist
group
statist
similar
tabl
among
patient
integr
group
patient
receiv
acupunctur
therapi
least
two
time
receiv
moxibust
therapi
receiv
cup
therapi
receiv
herbal
medic
receiv
physic
therapi
psychotherapi
result
divid
number
day
km
appli
day
present
figur
comparison
preval
hospit
two
group
perform
logist
regress
analysi
odd
ratio
calcul
preval
hospit
pneumoniasepsi
ci
time
lower
integr
therapi
group
monotherapi
group
p
preval
total
hospit
well
hospit
pd
dementia
depress
integr
therapi
group
posit
compar
monotherapi
group
differ
signific
addit
preval
total
hospit
hospit
pd
dementia
depress
pneumoniasepsi
show
posit
result
order
integr
group
ii
km
day
integr
group
km
less
day
monotherapi
group
differ
signific
tabl
comparison
annual
length
hospit
group
use
ttest
reveal
total
annual
length
hospit
annual
length
hospit
due
pd
annual
length
hospit
due
dementia
annual
length
hospit
due
depress
annual
length
hospit
due
pneumoniasepsi
shorter
integr
therapi
group
monotherapi
group
howev
differ
statist
signific
integr
therapi
group
divid
two
group
day
less
day
treatment
durat
anova
conduct
compar
monotherapi
group
preval
total
hospit
well
hospit
pd
dementia
depress
pneumoniasepsi
show
posit
result
order
integr
group
ii
km
day
integr
group
km
less
day
monotherapi
group
differ
signific
figur
cox
proport
hazard
model
use
compar
mortal
group
mortal
integr
therapi
group
found
patient
per
personyear
monotherapi
group
patient
per
personyear
hazard
ratio
hr
howev
differ
signific
typic
medic
pd
levodopa
howev
longterm
use
result
decreas
efficaci
motor
fluctuat
dyskinesia
patient
fahn
et
al
integr
therapi
group
ii
n
odd
ratio
ci
confid
interv
monotherapi
group
treat
biomedicin
integr
therapi
group
treat
biomedicin
km
integr
therapi
group
km
treatment
less
day
integr
therapi
group
ii
km
treatment
day
dt
due
pd
parkinson
diseas
statist
signific
p
preval
melanoma
pd
patient
take
levodopa
significantli
higher
gener
popul
shalabi
loui
dementia
pd
patient
common
complic
pd
make
treatment
difficult
lead
disabl
depress
also
common
complic
pd
brown
marsden
cum
infecti
diseas
pneumonia
consid
factor
increas
mortal
pd
patient
pinter
et
al
addit
patient
longer
durat
pd
complic
lower
qualiti
life
ou
et
al
subthalam
stimul
attempt
improv
qualiti
life
posit
result
howev
surgeri
accompani
unintend
advers
event
even
death
dafsari
et
al
therefor
use
rel
safe
treatment
regimen
cam
consid
studi
investig
whether
km
could
reduc
hospit
manag
pd
patient
south
korea
two
group
patient
integr
therapi
group
use
biomedicin
km
monotherapi
group
use
biomedicin
compar
ps
estim
match
base
confound
sex
age
comorbid
antiparkinson
medic
preval
hospit
pneumoniasepsi
significantli
lower
time
integr
therapi
group
monotherapi
group
tradit
medicin
may
benefici
immunomodulatori
effect
prevent
viral
infect
poon
et
al
sever
acut
respiratori
syndrom
sar
advantag
treatment
integr
chines
medicin
biomedicin
observ
compar
biomedicin
alon
especi
respect
improv
clinic
symptom
promot
recoveri
immun
function
reduct
treatment
durat
qiang
et
al
henc
km
seem
posit
effect
infecti
diseas
pneumonia
sepsi
outcom
integr
therapi
group
also
show
better
result
monotherapi
group
differ
signific
although
signific
differ
outcom
observ
studi
preval
durat
hospit
tend
lower
patient
receiv
km
specif
km
treatment
period
day
show
better
result
less
day
studi
shown
acupunctur
effect
treatment
pd
lee
lim
exampl
pd
patient
acupunctur
show
signific
improv
motor
function
compar
without
acupunctur
moreov
brain
imag
reveal
putamen
primari
motor
cortex
activ
patient
acupunctur
chae
et
al
korean
herbal
formula
chungsimyeoldatang
yeoldahansotang
induc
autophagi
prevent
diseas
associ
misfoldedaggreg
protein
variou
neurodegen
disord
includ
pd
bae
et
al
bae
et
al
china
patient
underw
cam
treatment
herbal
medic
primarili
rehabilit
exercis
acupunctur
treatment
effect
half
patient
receiv
produc
neg
result
patient
pan
et
al
addit
incid
preval
pd
asian
countri
includ
south
korea
shown
lower
europ
america
pringsheim
et
al
differ
may
result
genet
ethnic
differ
possibl
effect
cam
includ
km
rule
note
paper
sever
limit
first
number
subject
suffici
data
limit
therefor
sure
whether
nonsignific
result
due
absenc
relationship
group
lack
statist
power
accordingli
compar
studi
increas
durat
number
patient
requir
clarifi
effect
km
pd
second
assess
whether
pd
complic
wellcontrol
altern
outcomesrel
measur
preval
hospit
annual
length
hospit
pd
diagnosi
gener
outcom
pd
recoveri
manag
evalu
base
updr
scopa
howev
nhisnsc
contain
inform
consist
health
insur
claim
data
third
number
km
monotherapi
patient
small
korean
health
insur
system
pd
seriou
rare
diseas
regist
manag
govern
pd
patient
confirm
regist
cost
treatment
support
govern
addit
receiv
standard
drug
therapi
levodopa
regist
patient
also
concurr
use
km
herbal
formula
acupunctur
desir
therefor
studi
necessari
analyz
total
nation
insur
dataset
nhisnsc
use
studi
equival
popul
south
korea
clearli
identifi
integr
therapi
km
biomedicin
pd
manag
better
treatment
patient
compar
biomedicin
monotherapi
howev
found
clue
better
result
integr
therapi
howev
note
investig
increas
number
subject
need
studi
approv
institut
review
board
dongguk
univers
gyeongju
drg
irb
patient
consent
exempt
total
anonym
research
data
use
studi
